These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8354165)

  • 21. Immunohistochemical localization of carcinogen-metabolizing enzymes within the rat and hamster exocrine pancreas.
    Kawabata TT; Wick DG; Guengerich FP; Baron J
    Cancer Res; 1984 Jan; 44(1):215-23. PubMed ID: 6418377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ecological aggression and adaptation mechanisms].
    Liubchenko PN
    Med Tr Prom Ekol; 1996; (11):1-5. PubMed ID: 9213503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and inducibility of drug-metabolizing enzymes in novel murine liver epithelial cell lines and their ability to activate procarcinogens.
    Paolini M; Barone E; Corsi C; Paganin C; Revoltella RP
    Cancer Res; 1991 Jan; 51(1):301-9. PubMed ID: 1988092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens.
    Shimada T; Yun CH; Yamazaki H; Gautier JC; Beaune PH; Guengerich FP
    Mol Pharmacol; 1992 May; 41(5):856-64. PubMed ID: 1588920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptive responses to environmental chemicals.
    Wolf CR; Smith G; Smith AG; Brown K; Henderson CJ
    Biochem Soc Symp; 1999; 64():129-39. PubMed ID: 10207626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanism of phase I and phase II drug-metabolizing enzymes: implications for detoxification.
    Iyanagi T
    Int Rev Cytol; 2007; 260():35-112. PubMed ID: 17482904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic basis of toxic reactions to drugs and chemicals.
    Cascorbi I
    Toxicol Lett; 2006 Mar; 162(1):16-28. PubMed ID: 16310984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping of cytochrome P-450 distribution and function with monoclonal antibodies and cDNA expression.
    Gelboin HV; Park SS; Aoyama T; Fujino T; Crespi CL; Gonzalez FJ
    Princess Takamatsu Symp; 1990; 21():3-16. PubMed ID: 2134683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
    Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Environmental contaminants in pathogenesis of breast cancer.
    Mukherjee S; Koner BC; Ray S; Ray A
    Indian J Exp Biol; 2006 Aug; 44(8):597-617. PubMed ID: 16924830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and molecular detoxication.
    Cashman JR; Perotti BY; Berkman CE; Lin J
    Environ Health Perspect; 1996 Mar; 104 Suppl 1(Suppl 1):23-40. PubMed ID: 8722108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of xenobiotics and chemical carcinogenesis.
    Lang M; Pelkonen O
    IARC Sci Publ; 1999; (148):13-22. PubMed ID: 10493245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of metabolic polymorphisms in lung carcinogenesis].
    Kiyohara C; Ohno Y
    Nihon Koshu Eisei Zasshi; 1999 Apr; 46(4):241-9. PubMed ID: 10491856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of Cytochrome P450 Enzyme Induction and Inhibition in Human Hepatoma Cells.
    Rodrigues RM; De Kock J; Doktorova TY; Rogiers V; Vanhaecke T
    Methods Mol Biol; 2015; 1250():279-85. PubMed ID: 26272150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic polymorphisms and cancer susceptibility.
    Smith G; Stanley LA; Sim E; Strange RC; Wolf CR
    Cancer Surv; 1995; 25():27-65. PubMed ID: 8718512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbon-carbon bond cleavage and formation reactions in drug metabolism and the role of metabolic enzymes.
    Bolleddula J; Chowdhury SK
    Drug Metab Rev; 2015; 47(4):534-57. PubMed ID: 26390887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine.
    Bolt HM; Roos PH; Thier R
    Int Arch Occup Environ Health; 2003 Apr; 76(3):174-85. PubMed ID: 12690492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzymes involved in the metabolism of the carcinogen 2-nitroanisole: evidence for its oxidative detoxication by human cytochromes P450.
    Miksanová M; Sulc M; Rýdlová H; Schmeiser HH; Frei E; Stiborová M
    Chem Res Toxicol; 2004 May; 17(5):663-71. PubMed ID: 15144223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms.
    Ingelman-Sundberg M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):89-104. PubMed ID: 14574440
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.